Comparative Inhibitory Potential of Selected Dietary Bioactive Polyphenols, Phytosterols on CYP3A4 and CYP2D6 with Fluorometric High-throughput Screening

Overview

Journal J Food Sci Technol

Specialty Nutritional Sciences

Date 2015 Jul 4

PMID 26139922

Citations 18

Authors

Thangavel Mahalingam Vijayakumar

Ramasamy Mohan Kumar

Aruna Agrawal

Govind Prasad Dubey

Kaliappan Ilango

Affiliations

Soon will be listed here.

Abstract

Cytochrome P450 (CYP450) inhibition by the bioactive molecules of dietary supplements or herbal products leading to greater potential for toxicity of co-administered drugs. The present study was aimed to compare the inhibitory potential of selected common dietary bioactive molecules (Gallic acid, Ellagic acid, β-Sitosterol, Stigmasterol, Quercetin and Rutin) on CYP3A4 and CYP2D6 to assess safety through its inhibitory potency and to predict interaction potential with co-administered drugs. CYP450-CO complex assay was carried out for all the selected dietary bioactive molecules in isolated rat microsomes. CYP450 concentration of the rat liver microsome was found to be 0.474 nmol/mg protein, quercetin in DMSO has shown maximum inhibition on CYP450 (51.02 ± 1.24 %) but less when compared with positive control (79.02 ± 1.61 %). In high throughput fluorometric assay, IC50 value of quercetin (49.08 ± 1.02-54.36 ± 0.85 μg/ml) and gallic acid (78.46 ± 1.32-83.84 ± 1.06 μg/ml) was lower than other bioactive compounds on CYP3A4 and CYP2D6 respectively but it was higher than positive controls (06.28 ± 1.76-07.74 ± 1.32 μg/ml). In comparison of in vitro inhibitory potential on CYP3A4 and CYP2D6, consumption of food or herbal or dietary supplements containing quercetin and gallic acid without any limitation should be carefully considered when narrow therapeutic drugs are administered together.

Citing Articles

Effects of piperine-haloperidol mixture on ketamine induced schizophrenia rats and metabolism-mediated inhibitory potency: in-vivo and in-vitro evaluation.

Pradeepa B, Vijayakumar T, Manikandan K 3 Biotech. 2024; 14(12):314.

PMID: 39619819 PMC: 11602896. DOI: 10.1007/s13205-024-04160-x.

Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review).

Torres-Chavez M, Torres-Carrillo N, Monreal-Lugo A, Garnes-Rancurello S, Murugesan S, Gutierrez-Hurtado I Biomed Rep. 2023; 19(6):93.

PMID: 37901876 PMC: 10603378. DOI: 10.3892/br.2023.1675.

Antiproliferative and Anti-Inflammatory Activities of Deprungsith Formulation and Its Bioactive Compounds Against Mild Psoriasis and Potential of Metabolic Herb-Drug Interactions.

Na-Bangchang K, Teerachaisakul M, Muhamad P, Kasemnitichok Y, Sangnarong N, Boonprasert K J Evid Based Integr Med. 2023; 28:2515690X231191101.

PMID: 37553989 PMC: 10413907. DOI: 10.1177/2515690X231191101.

Effects of Dietary Flavonoids on the Metabolism of Vortioxetine and its Potential Mechanism.

Lin Y, Wang Y, Ye Z, Gao N, Xu X, Weng Q Curr Med Chem. 2023; 31(23):3624-3630.

PMID: 37287287 DOI: 10.2174/0929867330666230607104411.

Inhibition of Cytochrome P450s by Strobilanthes crispus Sub-Fraction (F3): Implication for Herb-Drug Interaction.

Yong Y, Liew M, Yaacob N Eur J Drug Metab Pharmacokinet. 2022; 47(3):431-440.

PMID: 35146636 DOI: 10.1007/s13318-022-00754-z.

References

Tang J, Yang H, Song X, Song X, Yan S, Shao J . Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes. Phytother Res. 2008; 23(2):159-64. DOI: 10.1002/ptr.2572. View

Erlund I, Silaste M, Alfthan G, Rantala M, Kesaniemi Y, Aro A . Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2002; 56(9):891-8. DOI: 10.1038/sj.ejcn.1601409. View

Ponnusankar S, Pandit S, Babu R, Bandyopadhyay A, Mukherjee P . Cytochrome P450 inhibitory potential of Triphala--a Rasayana from Ayurveda. J Ethnopharmacol. 2010; 133(1):120-5. DOI: 10.1016/j.jep.2010.09.022. View

Pandit S, Ponnusankar S, Bandyopadhyay A, Ota S, Mukherjee P . Exploring the possible metabolism mediated interaction of Glycyrrhiza glabra extract with CYP3A4 and CYP2D6. Phytother Res. 2011; 25(10):1429-34. DOI: 10.1002/ptr.3426. View

Gubler H, Schopfer U, Jacoby E . Theoretical and experimental relationships between percent inhibition and IC50 data observed in high-throughput screening. J Biomol Screen. 2012; 18(1):1-13. DOI: 10.1177/1087057112455219. View

Muti P, Awad A, Schunemann H, Fink C, Hovey K, Freudenheim J . A plant food-based diet modifies the serum beta-sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr. 2003; 133(12):4252-5. DOI: 10.1093/jn/133.12.4252. View

Hodek P, Trefil P, Stiborova M . Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact. 2002; 139(1):1-21. DOI: 10.1016/s0009-2797(01)00285-x. View

Stresser D, Blanchard A, Turner S, Erve J, Dandeneau A, Miller V . Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos. 2000; 28(12):1440-8. View

Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C . Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997; 409(1):12-6. DOI: 10.1016/s0014-5793(97)00467-5. View

10.

Noroozi M, Burns J, Crozier A, Kelly I, Lean M . Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000; 54(2):143-9. DOI: 10.1038/sj.ejcn.1600908. View

11.

Li X, Choi J . Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Anticancer Res. 2009; 29(4):1411-5. View

12.

DESCHNER E, Ruperto J, Wong G, Newmark H . The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer. 1993; 20(3):199-204. DOI: 10.1080/01635589309514287. View

13.

Zou L, Harkey M, Henderson G . Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci. 2002; 71(13):1579-89. DOI: 10.1016/s0024-3205(02)01913-6. View

14.

Bradford P, Awad A . Phytosterols as anticancer compounds. Mol Nutr Food Res. 2007; 51(2):161-70. DOI: 10.1002/mnfr.200600164. View

15.

Kim Y, Zerin T, Song H . Antioxidant action of ellagic acid ameliorates paraquat-induced A549 cytotoxicity. Biol Pharm Bull. 2013; 36(4):609-15. DOI: 10.1248/bpb.b12-00990. View

16.

Choi J, Piao Y, Kang K . Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res. 2011; 34(4):607-13. DOI: 10.1007/s12272-011-0411-x. View

17.

Mansouri M, Soltani M, Naghizadeh B, Farbood Y, Mashak A, Sarkaki A . A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze. Pharmacol Biochem Behav. 2013; 117:40-6. DOI: 10.1016/j.pbb.2013.12.011. View

18.

Ho P, Saville D, Wanwimolruk S . Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci. 2001; 4(3):217-27. View

19.

Subehan , Usia T, Iwata H, Kadota S, Tezuka Y . Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants. J Ethnopharmacol. 2006; 105(3):449-55. DOI: 10.1016/j.jep.2005.12.001. View

20.

Schroder-Aasen T, Molden G, Nilsen O . In vitro inhibition of CYP3A4 by the multiherbal commercial product Sambucus Force and its main constituents Echinacea purpurea and Sambucus nigra. Phytother Res. 2012; 26(11):1606-13. DOI: 10.1002/ptr.4619. View